DE1617463A1 - Process for the manufacture of injectable colloidal iron preparations - Google Patents

Process for the manufacture of injectable colloidal iron preparations

Info

Publication number
DE1617463A1
DE1617463A1 DE19661617463 DE1617463A DE1617463A1 DE 1617463 A1 DE1617463 A1 DE 1617463A1 DE 19661617463 DE19661617463 DE 19661617463 DE 1617463 A DE1617463 A DE 1617463A DE 1617463 A1 DE1617463 A1 DE 1617463A1
Authority
DE
Germany
Prior art keywords
manufacture
iron
heated
colloidal iron
iron preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19661617463
Other languages
German (de)
Inventor
Klaus Dr Bauer
Gerhard Dr Sagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of DE1617463A1 publication Critical patent/DE1617463A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/295Iron group metal compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

FARBENFABRIKEN BAYER AGFARBENFABRIKEN BAYER AG

LEVERKUSEN-Biyerwerk 26. NOV. 1969LEVERKUSEN-Biyerwerk 26 NOV. 1969

P 16 17 463-3 p«tent-Ab«iiung si/Sc P 16 17 463-3 p «tent-Ab« iiung si / Sc

Verfahren zur Herstellung von injizierbaren kolloidalen Eisenzubereitungen Process for the manufacture of injectable colloidal iron preparations

Es ist bekannt, daß man zur Herstellung injizierbarer kolloidaler Ei3enzubereitungen Polysaccharide in alkalischer Lösung in Gegenwart von Wasserstoffperoxid mit Ferrisalzen erhitzt und den dabei entstehenden Polysaceharid-Eisen-Komplex, gegebenenfalls durch Zusatz von Chelat-bildenden Hydroxysäuren "bzw. deren Salzen,in wäßrige Lösung bringt.It is known that one can produce injectable colloidal egg preparations with polysaccharides in alkaline solution in the presence of hydrogen peroxide Ferric salts are heated and the resulting polysacharide-iron complex, optionally by adding chelate-forming hydroxy acids "or their salts, in brings aqueous solution.

Bs wurde nun gefunden, daß ein Abbau der Polysaccharide mit Wasserstoffperoxid auch in neutraler oder schwach saurer Lösung stattfindet, und daß dabei solche Polymerhomologen entstehen, die sich zur Herstellung von kolloidalen Eisenzubereitungen eignen.It has now been found that a degradation of the polysaccharides with hydrogen peroxide also takes place in neutral or weakly acidic solution, and that such polymer homologs which are suitable for the production of colloidal iron preparations.

Zweckmäßig geht man dabei so vor, daß man eine wäßrige Lösung des Polysaccharids mit Wasserstoffperoxid versetzt und so lange zum Sieden erhitzt, bis der Abbau den gewünschten Grad erreicht hat. Die Lösung wird während das AbbausIt is expedient to proceed in such a way that an aqueous solution of the polysaccharide is mixed with hydrogen peroxide and heated to the boil until the degradation has reached the desired level. The solution becomes during the breakdown

im allgemeinen schach sauer. Bei extrem säureempfindlichen Polysacchariden»wie z.B. Laevan,ist es daher zweckmäßig, die Lösungen vor dem Abbau zu puffern.generally angry at chess. For extremely acid-sensitive Polysaccharides »such as Laevan, it is therefore advisable to to buffer the solutions before dismantling.

Die abgebauten Polysaccharide werden, wie im Hauptpatent beschrieben, bei einem pH-Wert, der höher als 8 sein soll, mit Ferrisalzen umgesetzt. Zum Einstellen des pH-Wertes auf über'8 eignen sich anorganische Basenfwie z.B. Natronlauge oder Kalilauge, oder organische Basent wie z.B. Triethylamin. Die Erzeugnisse des erfindungsgemäßen Verfahrens eignen sich für die Therapie mit dreiwertigem Eisen, vor allem in der Veterinärmedizin.As described in the main patent, the degraded polysaccharides are reacted with ferric salts at a pH value that should be higher than 8. Inorganic bases f, such as sodium hydroxide solution or potassium hydroxide solution, or organic bases t such as triethylamine, for example, are suitable for setting the pH value above 8. The products of the method according to the invention are suitable for therapy with trivalent iron, especially in veterinary medicine.

Beispiel 1example 1

16,2 g wasserlösliche Stärke werden in 400 ml Wasser gelöst und mit 2,5 ml 30-^igem Wasserstoffperoxid versetzt. Darm wird 7 Stunden zum Sieden erhitzt, mit 40 ml Triäthylamin versetst und tropfenweise 70 ml einer 30-$igen Eisenchloridlösung zugegeben. Der Ansatz wird eine Stunde bei ca. 8O0C weitergerührt, durch Zentrifugieren geklärt und mit Methanol gefällt. Nach einmaligem Umfallen aus Methanol erhält man einen Eisen-Stärke-Komplex. Ausbeute 12,8 g; Eisengehalt: 24,8 <fi. 16.2 g of water-soluble starch are dissolved in 400 ml of water and treated with 2.5 ml of 30% hydrogen peroxide. The intestine is heated to the boil for 7 hours, mixed with 40 ml of triethylamine and 70 ml of a 30% ferric chloride solution are added dropwise. The mixture is further stirred for one hour at about 8O 0 C, clarified by centrifugation, and precipitated with methanol. After a single reprecipitation from methanol, an iron-starch complex is obtained. Yield 12.8 g; Iron content: 24.8 <fi.

40 g des Eisen-Stärke-Komplexes werden in wenig Wasser in der Wärme gelöst und auf 100 ecm nach Einstellen des pH-Wertes auf 6,3 aufgefüllt. Dann wird mit Kochsalz isotonisch gemacht. Die Sterilisation erfolgt durch 1/2-stündiges Erhitzen auf 1050C, Man erhält οine injizierbare Lösung des Eisen-Komplexes mit einem Gehalt von 100 mg/ml Eisen.40 g of the iron-starch complex are dissolved in a little warm water and made up to 100 ecm after adjusting the pH to 6.3. Then it is made isotonic with table salt. Sterilization is carried out with 1/2-hour heating at 105 0 C, οine injectable solution of the iron complex is obtained with a content of 100 mg / ml of iron.

BAD ORfQfNALBAD ORfQfNAL

I AI A

Beispiel 2Example 2

16,2 g lösliche Stärke v/erden in 400 ml Wasser gelöst und mit 10 ml 3Q-$igem Wasserstoffperoxid versetzt. Die Lösung wird 2 1/2 Stunden zum Sieden erhitzt und entsprechend Beispiel 1 aufgearbeitet.
Ausbeute: 14,0 gj Eisengehalt: 25,4 i<>.
16.2 g of soluble starch are dissolved in 400 ml of water and treated with 10 ml of 3Q hydrogen peroxide. The solution is heated to boiling for 2 1/2 hours and worked up as in Example 1.
Yield: 14.0 g / Iron content: 25.4% .

Beispiel 3Example 3

-16,2 g natives Laevan werden* in 400 ml m/15 Acetatpuffer vom pH 5,5 gelöst und mit 5,0 ecm 30-$igem Wasserstoffperoxid versetzt. Der Ansatz wird drei Stunden zum Sieden erhitzt und entsprechend Beispiel 1 aufgearbeitet. Ausbeute: 13t 2 g; Eisengehalt: 25,8 $.-16.2 g of native Laevan are * in 400 ml of m / 15 acetate buffer dissolved from pH 5.5 and with 5.0 ecm 30- $ hydrogen peroxide offset. The batch is heated to boiling for three hours and worked up as in Example 1. Yield: 13t 2 g; Iron content: $ 25.8.

Le A 10 130 " ■· . - 3 -L e A 1 0 130 "■ ·. - 3 -

109815/1814109815/1814

Claims (1)

Pat ent anspruchPatent entitlement Verfahren zur Herstellung von injizierbaren kolloidalen Eisensubereitungen, dadurch gekennzeichnet, daß nan Polysaccharide in neutraler oder schwach saurer Reaktion mit Wasserstoffperoxid erhitzt, das Reaktionsgemisch bei einem pH-Wert, der über 8 liegt, mit Ferrisalzen erhitzt und den Polysaccharid-Eisen-Koniplex in üblicher Weise isoliert.Process for the preparation of injectable colloidal Iron preparations, characterized in that nan polysaccharides heated in a neutral or weakly acidic reaction with hydrogen peroxide, the reaction mixture at a pH value above 8 is heated with ferric salts and the polysaccharide-iron complex is isolated in the usual way. Le A 10 130 - 4 - Le A 10 130 - 4 - 109816/1*14109816/1 * 14
DE19661617463 1965-11-20 1966-07-11 Process for the manufacture of injectable colloidal iron preparations Pending DE1617463A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEF0047736 1965-11-20
DEF0049667 1966-07-11

Publications (1)

Publication Number Publication Date
DE1617463A1 true DE1617463A1 (en) 1971-04-08

Family

ID=25977057

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19661617463 Pending DE1617463A1 (en) 1965-11-20 1966-07-11 Process for the manufacture of injectable colloidal iron preparations

Country Status (4)

Country Link
BE (1) BE689779A (en)
DE (1) DE1617463A1 (en)
GB (1) GB1111929A (en)
NL (1) NL6616205A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1190719A1 (en) * 2000-08-17 2002-03-27 B. Braun Melsungen Ag Colloidal pharmacomodulation of injected pharmaceutical compositions

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU187167B (en) * 1982-10-15 1985-11-28 Richter Gedeon Vegyeszet Process for producing pharmaceutical solution of new type polynuclear iron/iii/ mixed complex activity
CN1376036A (en) 1999-08-31 2002-10-23 药物研究有限公司 Metal-containing compositions, preparations and uses
RU2003121403A (en) * 2000-12-07 2004-12-27 АД "ЗДРАВЛЬЕ" Фармасеутско-кемийска индустри , Сентар за истразиванье и развой (YU) POLYNUCLEAR COMPLEX FE (III) WITH PULULANAN OLIGOMERS, METHOD OF ITS PRODUCTION AND PHARMACEUTICAL PRODUCTS ON ITS BASIS
DE10249552A1 (en) 2002-10-23 2004-05-13 Vifor (International) Ag Water-soluble iron-carbohydrate complexes, their preparation and medicaments containing them
EP1947120A1 (en) 2007-01-19 2008-07-23 Vifor (International) Ag Iron-carbohydrate complex compounds
CN109134683B (en) * 2018-09-25 2021-01-15 武汉轻工大学 Preparation method and application of pyracantha polysaccharide-iron complex

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1190719A1 (en) * 2000-08-17 2002-03-27 B. Braun Melsungen Ag Colloidal pharmacomodulation of injected pharmaceutical compositions

Also Published As

Publication number Publication date
NL6616205A (en) 1967-05-22
BE689779A (en) 1967-05-16
GB1111929A (en) 1968-05-01

Similar Documents

Publication Publication Date Title
EP0044050B1 (en) Process for preparing ferrihydroxide-dextran complexes, and a pharmaceutical sterile solution containing them
DE1617463A1 (en) Process for the manufacture of injectable colloidal iron preparations
DE1293144B (en) Process for the production of complex compounds of iron with sorbitol, gluconic acid and an oligosaccharide
DE1196629B (en) Process for the production of nonionic, therapeutically usable ferric hydroxide-dextran complexes
DE208961C (en)
DE2124904B2 (en) Hydroxy- and alkoxyacetamido-triiodobenzoic acids, their salts with physiologically compatible bases, processes for their preparation and X-ray contrast media containing these compounds
DE556458C (en) Process for the preparation of catechinaric acids
DE2042324A1 (en)
AT263814B (en) Process for the production of a new poly-γ-propylsulfonic acid ether of inulin
DE270255C (en)
DE245572C (en)
DE629841C (en) Process for the preparation of an aqueous quinine solution for injection purposes
DE540328C (en) Process for the preparation of easily soluble complex double salts of cyano mercuriphenols
AT63163B (en) Process for the production of protein-containing, easily absorbable iron salts of the assimilable phosphorus compound contained in the plants (inositol phosphoric acid).
DE296917C (en)
DE208189C (en)
DE258297C (en)
DE343150C (en) Process for the preparation of salts of the compounds of tannic acid or gallic acid and lactic acid
DE417973C (en) Process for the production of colloidal metal solutions
AT152741B (en) Process for the preparation of formaldehyde sodium sulfoxylates from arsenobenzene compounds.
AT155149B (en) Process for the preparation of formaldehyde sodium sulfoxylates from arsenobenzene compounds.
DE261875C (en)
DE445647C (en) Process for the preparation of derivatives of nuclear mercured phenols
DE242776C (en)
AT119474B (en) Process for the preparation of substitution products of ß-iodopyridine.